Muireann Bolger

Key details

Muireann Bolger is deputy editor of World Intellectual Property Review and Life Sciences Intellectual Property Review in London, where she covers trademarks, brands, as well as wider developments across the intellectual property sector.

She regularly attends and covers major IP conferences around the world, reporting on the latest legal, commercial and policy developments and interviewing leading figures from across the sector. She has also co-authored industry reports with leading IP organisations, including the International Trademark Association (INTA).

She is the editor of the website’s Community & Inclusion channel and the annual Influential Women in IP list, which celebrates the achievements and contributions of leading women across the IP sector.

Originally from Ireland, Muireann has nearly two decades of experience reporting on brand developments, strategy, and wider business issues.

In her current role, she writes and edits news and analysis for an international audience of IP professionals, while also championing inclusion within the profession.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 415

Articles by Muireann Bolger

Pfizer beats Novo Nordisk in $10bn bidding war
Americas
US Federal Trade Commission’s antitrust warning tipped the scales in Pfizer’s favour, ending a heated dispute over a weight-loss biotech.   13 November 2025
Pfizer can’t block Novo Nordisk’s $10bn takeover deal
Pharma
Judge delivers major setback to pharma giant’s efforts to scupper rival’s surprise bid, in an increasingly bitter feud over an obesity drug biotech.   6 November 2025
Novartis counsel warns: ‘Don’t let AI develop without our input’
Americas
With AI reshaping IP enforcement, the pharma giant’s IP head warns that only active guidance will stop the industry from lagging behind, reports Muireann Bolger.   3 November 2025
Americas
With fraudsters exploiting new technologies, the company’s Kenya Williams explains why vigilant enforcement is money well spent to maintain a ‘clean’ brand.   29 October 2025
Europe
The tech is being used to crunch thousands of documents in billion-dollar mediations and emerging as a valuable party at the table, finds Muireann Bolger.   28 October 2025
Pharma
A new report highlights widespread mental health issues among legal professionals, leading to poor wellbeing and career disillusionment.   10 October 2025
Americas
The pharma giant extends market exclusivity for a top-selling drug accounting for nearly half of its multi-billion-dollar sales.   9 October 2025
Americas
As a US federal shutdown grips IP-critical agencies, layoffs, office closures, and resource cutbacks are underway at the US Patent and Trademark Office.   2 October 2025
Americas
Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and supply chain risks.   26 September 2025
Europe
From trademark decisions to judicial writing, the IP community is embracing AI but questions loom about quality, precedents, and jurisdictional limits. Muireann Bolger reports from Marques’ annual meeting.   18 September 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.